Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating viral hemorrhagic fever.

Albert T A Mairuhu1, Dees P M Brandjes, Eric C M van Gorp

  • 1Slotervaart Hospital, Department of Internal Medicine, Louwesweg 6, 1066 EC Amsterdam, the Netherlands. igrmr@slz.nl

Idrugs : the Investigational Drugs Journal
|November 6, 2003
PubMed
Summary

Viral hemorrhagic fevers (VHFs) are tropical diseases with emerging viruses. Recent advances improve supportive care and identify new antiviral treatments for these dangerous infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory Biomarkers as Mediators of the Effect Between High-Dose Corticosteroid Therapy and Mortality in COVID-19-Related ARDS: A Causal Mediation Analysis.

Immunity, inflammation and disease·2026
Same author

Exploring blood transcriptional signatures for thrombosis diagnosis in critically ill patients with COVID-19.

Blood vessels, thrombosis & hemostasis·2026
Same author

High-Dose Corticosteroids in Critically Ill COVID-19 Patients: A Retrospective Cohort Study from Suriname.

Journal of inflammation research·2025
Same author

Increasing inflammatory biomarkers are associated with mortality in critically ill COVID-19 patients despite anti-inflammatory treatment.

Clinical and experimental medicine·2025
Same author

In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Inflammatory Biomarkers Demonstrate Predictive Capacity for Mortality in COVID-19-Related ARDS Patients Receiving High-Dose Corticosteroids: A Longitudinal Analysis.

Journal of inflammation research·2025

Area of Science:

  • * Infectious Diseases: Focus on viral hemorrhagic fevers.
  • * Virology: Study of emerging and re-emerging hemorrhagic fever viruses.

Background:

  • * Viral hemorrhagic fevers (VHFs) are a group of severe infectious diseases primarily found in tropical regions.
  • * Recent decades have seen the emergence of novel VHF-causing viruses, increasing global health concerns.
  • * Understanding the pathophysiology of VHFs is crucial for effective management.

Purpose of the Study:

  • * To review the therapeutic aspects of viral hemorrhagic fever viruses.
  • * To highlight recent advancements in the treatment of VHF pathogens.
  • * To provide an overview of current and emerging therapeutic strategies for VHFs.

Main Methods:

  • * Literature review of recent scientific publications on VHF treatment.
  • * Analysis of studies focusing on antiviral agents and supportive care for VHFs.
  • * Synthesis of information on the pathophysiology and therapeutic progress for hemorrhagic fever viruses.

Main Results:

  • * Improved understanding of VHF pathophysiology has enhanced initial supportive management.
  • * Several potentially effective antiviral agents for VHFs have been identified.
  • * Progress in therapeutic interventions offers new hope for managing VHF infections.

Conclusions:

  • * Therapeutic strategies for viral hemorrhagic fevers have advanced significantly.
  • * Continued research into antiviral agents and supportive care is vital for combating VHFs.
  • * Recent progress provides a more optimistic outlook for the treatment of these challenging viral diseases.

Related Experiment Videos